Lei Kong1,2,3,4, Jin Xu5,6,7,8, Mengqi Zhang9,10,11,12, Yan Wang9,10,11,12, Zhikun Huan9,10,11,12, Yaping Liu9,10,11,12,13, Wenwen Zhang9,10,11,12,14, Dehuan Kong15. 1. School of Medicine, Shandong University, jinan, 250021, shandong, China. lgkonglei@hotmail.com. 2. Department of Endocrinology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jina, 250021, Shandong, China. lgkonglei@hotmail.com. 3. Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China. lgkonglei@hotmail.com. 4. Shandong Provincial Key Laboratory of Endocrinology and Lipid Metabolism, Jinan, Shandong, China. lgkonglei@hotmail.com. 5. School of Medicine, Shandong University, jinan, 250021, shandong, China. xujin267903@163.com. 6. Department of Endocrinology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jina, 250021, Shandong, China. xujin267903@163.com. 7. Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China. xujin267903@163.com. 8. Shandong Provincial Key Laboratory of Endocrinology and Lipid Metabolism, Jinan, Shandong, China. xujin267903@163.com. 9. School of Medicine, Shandong University, jinan, 250021, shandong, China. 10. Department of Endocrinology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jina, 250021, Shandong, China. 11. Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China. 12. Shandong Provincial Key Laboratory of Endocrinology and Lipid Metabolism, Jinan, Shandong, China. 13. Department of Endocrinology, Jining No.1 People's Hospital, No.6 Health Road, Jining, 272011, China. 14. Scientific Center, Shandong Provincial Hospital Affiliated To Shandong University, Jinan, Shandong, China. 15. Department of Geriatrics, Taian City Central Hospital, Taian, Shandong, China.
Abstract
INTRODUCTION: Osteoarthritis (OA) is a common joint disease characterized by articular cartilage degeneration. The prevalence of OA is higher among women than men, and this prevalence is closely related to menopause. The classic view assumes that the underlying mechanism of postmenopausal OA is attributed to declining estrogen levels. Although follicle-stimulating hormone (FSH) levels become elevated in parallel, the effects of FSH on OA have been poorly explored. The present study aimed to study the effect of FSH on cartilage metabolism. METHODS: Chondrocyte-like ATDC5 cells were treated with recombinant FSH protein. Then the cell viability was measured using cell counting kit-8 assay. Expressions of crucial factors involved in the extracellular matrix (ECM) metabolic and PKA-CREB-SOX9 pathway were analyzed by western blot, RT-qPCR, and immunofluorescence staining. Intracellular cAMP levels were assessed by ELISA assay. Experimental OA in mice was induced by destabilization of the medial meniscus (DMM) surgery. Adeno-associated virus expressing shRNA against FSHR (AAV-shFSHR) was intra-articular (IA) injected into the OA model animals to specifically knock down FHSR in cartilage. Histological staining and OARSI scores were used to assess the efficacy of AAV-shFSHR injections. RESULTS: We found that FSH down-regulated the expression of ECM-related proteins in chondrocyte-like ATDC5 cells. The underlying mechanism is probably associated with regulating PKA/CREB/SOX9 pathway. Besides, blocking FSH signaling via shRNA-mediated downregulation of FSHR in joint tissues effectively delayed the development of posttraumatic OA in mice. CONCLUSIONS: Our results collectively indicated that FSH plays an essential role in the pathogenesis of OA and acts as a crucial mediator.
INTRODUCTION:Osteoarthritis (OA) is a common joint disease characterized by articular cartilage degeneration. The prevalence of OA is higher among women than men, and this prevalence is closely related to menopause. The classic view assumes that the underlying mechanism of postmenopausal OA is attributed to declining estrogen levels. Although follicle-stimulating hormone (FSH) levels become elevated in parallel, the effects of FSH on OA have been poorly explored. The present study aimed to study the effect of FSH on cartilage metabolism. METHODS: Chondrocyte-like ATDC5 cells were treated with recombinant FSH protein. Then the cell viability was measured using cell counting kit-8 assay. Expressions of crucial factors involved in the extracellular matrix (ECM) metabolic and PKA-CREB-SOX9 pathway were analyzed by western blot, RT-qPCR, and immunofluorescence staining. Intracellular cAMP levels were assessed by ELISA assay. Experimental OA in mice was induced by destabilization of the medial meniscus (DMM) surgery. Adeno-associated virus expressing shRNA against FSHR (AAV-shFSHR) was intra-articular (IA) injected into the OA model animals to specifically knock down FHSR in cartilage. Histological staining and OARSI scores were used to assess the efficacy of AAV-shFSHR injections. RESULTS: We found that FSH down-regulated the expression of ECM-related proteins in chondrocyte-like ATDC5 cells. The underlying mechanism is probably associated with regulating PKA/CREB/SOX9 pathway. Besides, blocking FSH signaling via shRNA-mediated downregulation of FSHR in joint tissues effectively delayed the development of posttraumatic OA in mice. CONCLUSIONS: Our results collectively indicated that FSH plays an essential role in the pathogenesis of OA and acts as a crucial mediator.
Authors: Li Sun; Yuanzhen Peng; Allison C Sharrow; Jameel Iqbal; Zhiyuan Zhang; Dionysios J Papachristou; Samir Zaidi; Ling-Ling Zhu; Beatrice B Yaroslavskiy; Hang Zhou; Alberta Zallone; M Ram Sairam; T Rajendra Kumar; Wei Bo; Jonathan Braun; Luis Cardoso-Landa; Mitchell B Schaffler; Baljit S Moonga; Harry C Blair; Mone Zaidi Journal: Cell Date: 2006-04-21 Impact factor: 41.582
Authors: Velandai K Srikanth; Jayne L Fryer; Guangju Zhai; Tania M Winzenberg; David Hosmer; Graeme Jones Journal: Osteoarthritis Cartilage Date: 2005-09 Impact factor: 6.576
Authors: MaryFran R Sowers; Huiyong Zheng; Mary L Jannausch; Daniel McConnell; Bin Nan; Sioban Harlow; John F Randolph Journal: J Clin Endocrinol Metab Date: 2010-03-09 Impact factor: 5.958
Authors: Zhisong Zhang; Kaising Sun; Chonnakarn Jatchavala; John Koh; Yimian Chia; Jessica Bose; Zhimeng Li; Wanqiu Tan; Sizhe Wang; Wenjing Chu; Jiayun Wang; Bach Tran; Roger Ho Journal: Int J Environ Res Public Health Date: 2019-12-31 Impact factor: 3.390